Cargando…
Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
BACKGROUND: Positioning infliximab (IFX), cyclosporine and tacrolimus (TAC) for treating ulcerative colitis (UC) is in great debate. METHODS: A literature search identified studies that investigated IFX vs. cyclosporine or IFX vs TAC in UC patients. Short-term remission, short-term, 1-year and 3-yea...
Autores principales: | Jia, Xuemei, Guo, Ruitong, Hu, Zhenbiao, Liu, Jianxin, Liu, Jianping, Li, Bolin, Yang, Qian, He, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598782/ https://www.ncbi.nlm.nih.gov/pubmed/33126341 http://dx.doi.org/10.1097/MD.0000000000022894 |
Ejemplares similares
-
Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
por: Wang, Xueqi, et al.
Publicado: (2022) -
Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017) -
Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
por: Mizoshita, Tsutomu, et al.
Publicado: (2017) -
Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
por: Liu, Yi-Juan, et al.
Publicado: (2018) -
Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Lu, Jinhua, et al.
Publicado: (2020)